Recent Finacing
Recent Raise
Genexys BioMed is a preclinical genetic-medicine company developing a modular organic polymer delivery platform for non-viral, non-lipid pulmonary delivery of large mRNA/DNA payloads with cell-type targeting and reduced immunogenicity.
